Business Insider

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

FLORHAM PARK, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for ...
Psychology Today

What's Going on With Generic Stimulants?

I open my emails to find yet another message from a patient about their amphetamine-dextroamphetamine (the generic form of Aderall) no longer working. Dr. Plutchik, my meds no longer seem to be ...
Reuters

Indian drugmakers get regulatory nod to sell generic Wegovy, heating obesity‑drug race

The companies, which are yet to announce the approval, did not immediately respond to Reuters' request for a comment. Sun Pharma, which is India's largest drugmaker by revenue, on Friday announced ...
ProPublica

ProPublica Publishes Unreleased Data on the Origins of Generic Prescription Drugs

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...
MarketWatch

Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight

-- Dominance of VOQUEZNA: VOQUEZNA (vonoprazan), developed by Phathom Pharmaceuticals, is the first approved PCAB for GERD in the US and delivers faster onset, more consistent acid suppression, and ...
STAT

Supreme Court agrees to review ‘skinny labeling’ and generic drug access

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
PBS

Investigation raises concerns about lack of FDA quality testing for generic drugs

But a ProPublic investigation found that the FDA rarely tests the quality of generic drugs, many of them manufactured overseas. National reporter Debbie Cenziper of ProPublica was one of the authors ...
ProPublica

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
The Shreveport Times

Generic Vyvanse may not be working like it should. What to know about nationwide recall

Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...
The Shreveport Times

ADHD medicine not working like it should? It could be mislabeled bottles from August recall

Adderall is a central nervous system stimulant prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
Monthly Prescribing Reference

FDA Approves First Generic Version of Premarin Tablets

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...